Exome Asset Management LLC / KRYS
Exome Asset Management LLC’s Krystal Biotech Inc Position
Does Exome Asset Management LLC own Krystal Biotech Inc (KRYS)? Not currently — the last reported position was 14.7K shares worth $3M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q1 2024
Shares
14.7K
% of Portfolio
+2.24%
Quarters Held
1
position exited
Position History KRYS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2024 | 14.7K | $3M | +2.24% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of KRYS.